Litcius/Paper detail

An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii

Christopher E. Morgan, Zhemin Zhang, Robert A. Bonomo, Edward Yu

2022mBio25 citationsDOIOpen Access PDF

Abstract

Treatment of antibiotic-resistant organisms such as A. baumannii represents an ongoing issue for modern medicine. The multidrug efflux pump AdeJ serves as a major resistance determinant in A. baumannii through its action of extruding antibiotics from the cell. In this work, we use cryo-EM to show how AdeJ recognizes the experimental tetracycline antibiotic TP-6076 and prevents this drug from interacting with the A. baumannii ribosome. Since AdeJ and the ribosome use different binding modes to stabilize interactions with TP-6076, exploiting these differences may guide future drug development for combating antibiotic-resistant A. baumannii and potentially other strains of MDR bacteria.

Topics & Concepts

Acinetobacter baumanniiEffluxTetracyclineAntibioticsMicrobiologyMultiple drug resistanceRibosomeAntibiotic resistanceBiologyComputational biologyChemistryBacteriaRNABiochemistryGeneticsGenePseudomonas aeruginosaAntibiotic Resistance in BacteriaEscherichia coli research studiesBacterial Genetics and Biotechnology
An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii | Litcius